The IMPACT Trial: Single Inhaler Triple Therapy vs dual therapies. Consistent benefit across multiple exacerbation endpoints

Research output: Contribution to journalConference abstract in journalResearchpeer-review

  • MeiLan K. Han
  • Gerard Criner
  • Mark Dransfield
  • David Halpin
  • C. Elaine Jones
  • Sally Kilbride
  • Lange, Peter
  • David Lomas
  • Fernando Martinez
  • Holly Quasny
  • David Singh
  • Robert Wise
  • David Lipson
Original languageEnglish
Article numberPA2483
JournalEuropean Respiratory Journal
Volume54
Issue numberSupplement 63
ISSN0903-1936
DOIs
Publication statusPublished - 2019

    Research areas

  • COPD - exacerbations, COPD - management

ID: 235340940